vs

Side-by-side financial comparison of AbCellera Biologics Inc. (ABCL) and Cipher Mining Inc. (CIFR). Click either name above to swap in a different company.

Cipher Mining Inc. is the larger business by last-quarter revenue ($59.7M vs $44.9M, roughly 1.3× AbCellera Biologics Inc.). AbCellera Biologics Inc. runs the higher net margin — -19.9% vs -1229.6%, a 1209.7% gap on every dollar of revenue. On growth, AbCellera Biologics Inc. posted the faster year-over-year revenue change (788.4% vs 41.4%). AbCellera Biologics Inc. produced more free cash flow last quarter ($-44.6M vs $-695.9M). Over the past eight quarters, AbCellera Biologics Inc.'s revenue compounded faster (112.3% CAGR vs 11.4%).

AbCellera Biologics Inc. is a Vancouver, British Columbia-based biotechnology company that discovers and develops antibody therapeutics. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia.

Cipher Mining, Inc. operates as a Bitcoin mining ecosystem in the United States. The firm is developing a cryptocurrency business.

ABCL vs CIFR — Head-to-Head

Bigger by revenue
CIFR
CIFR
1.3× larger
CIFR
$59.7M
$44.9M
ABCL
Growing faster (revenue YoY)
ABCL
ABCL
+747.0% gap
ABCL
788.4%
41.4%
CIFR
Higher net margin
ABCL
ABCL
1209.7% more per $
ABCL
-19.9%
-1229.6%
CIFR
More free cash flow
ABCL
ABCL
$651.3M more FCF
ABCL
$-44.6M
$-695.9M
CIFR
Faster 2-yr revenue CAGR
ABCL
ABCL
Annualised
ABCL
112.3%
11.4%
CIFR

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ABCL
ABCL
CIFR
CIFR
Revenue
$44.9M
$59.7M
Net Profit
$-8.9M
$-734.2M
Gross Margin
59.4%
Operating Margin
-63.7%
-503.4%
Net Margin
-19.9%
-1229.6%
Revenue YoY
788.4%
41.4%
Net Profit YoY
73.9%
-4293.1%
EPS (diluted)
$-0.03
$-1.91

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ABCL
ABCL
CIFR
CIFR
Q4 25
$44.9M
$59.7M
Q3 25
$9.0M
$71.7M
Q2 25
$17.1M
$43.6M
Q1 25
$4.2M
$49.0M
Q4 24
$5.0M
$42.2M
Q3 24
$6.5M
$24.1M
Q2 24
$7.3M
$36.8M
Q1 24
$10.0M
$48.1M
Net Profit
ABCL
ABCL
CIFR
CIFR
Q4 25
$-8.9M
$-734.2M
Q3 25
$-57.1M
$-3.3M
Q2 25
$-34.7M
$-45.8M
Q1 25
$-45.6M
$-39.0M
Q4 24
$17.5M
Q3 24
$-51.1M
$-86.8M
Q2 24
$-36.9M
$-15.3M
Q1 24
$-40.6M
$39.9M
Gross Margin
ABCL
ABCL
CIFR
CIFR
Q4 25
59.4%
Q3 25
62.7%
Q2 25
64.8%
Q1 25
69.6%
Q4 24
56.9%
Q3 24
37.5%
Q2 24
61.2%
Q1 24
69.2%
Operating Margin
ABCL
ABCL
CIFR
CIFR
Q4 25
-63.7%
-503.4%
Q3 25
-851.8%
-52.5%
Q2 25
-290.2%
-103.9%
Q1 25
-1479.6%
-77.8%
Q4 24
40.5%
Q3 24
-1439.4%
-379.2%
Q2 24
-1276.2%
-43.9%
Q1 24
-551.5%
97.2%
Net Margin
ABCL
ABCL
CIFR
CIFR
Q4 25
-19.9%
-1229.6%
Q3 25
-637.8%
-4.6%
Q2 25
-203.3%
-105.1%
Q1 25
-1077.2%
-79.6%
Q4 24
41.5%
Q3 24
-785.4%
-359.9%
Q2 24
-504.3%
-41.5%
Q1 24
-408.0%
82.9%
EPS (diluted)
ABCL
ABCL
CIFR
CIFR
Q4 25
$-0.03
$-1.91
Q3 25
$-0.19
$-0.01
Q2 25
$-0.12
$-0.12
Q1 25
$-0.15
$-0.11
Q4 24
$0.04
Q3 24
$-0.17
$-0.26
Q2 24
$-0.13
$-0.05
Q1 24
$-0.14
$0.13

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ABCL
ABCL
CIFR
CIFR
Cash + ST InvestmentsLiquidity on hand
$128.5M
$628.3M
Total DebtLower is stronger
$2.7B
Stockholders' EquityBook value
$966.9M
$805.5M
Total Assets
$1.4B
$4.3B
Debt / EquityLower = less leverage
3.37×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ABCL
ABCL
CIFR
CIFR
Q4 25
$128.5M
$628.3M
Q3 25
$83.2M
$1.2B
Q2 25
$92.4M
$62.7M
Q1 25
$159.3M
$23.2M
Q4 24
$156.3M
$5.6M
Q3 24
$126.6M
$25.3M
Q2 24
$148.3M
$122.6M
Q1 24
$123.6M
$88.7M
Total Debt
ABCL
ABCL
CIFR
CIFR
Q4 25
$2.7B
Q3 25
$1.0B
Q2 25
$167.1M
Q1 25
Q4 24
$0
Q3 24
Q2 24
Q1 24
Stockholders' Equity
ABCL
ABCL
CIFR
CIFR
Q4 25
$966.9M
$805.5M
Q3 25
$964.0M
$783.2M
Q2 25
$1.0B
$748.9M
Q1 25
$1.0B
$734.8M
Q4 24
$1.1B
$682.0M
Q3 24
$1.1B
$672.0M
Q2 24
$1.1B
$690.8M
Q1 24
$1.1B
$600.9M
Total Assets
ABCL
ABCL
CIFR
CIFR
Q4 25
$1.4B
$4.3B
Q3 25
$1.4B
$2.8B
Q2 25
$1.4B
$1.0B
Q1 25
$1.3B
$913.8M
Q4 24
$1.4B
$855.4M
Q3 24
$1.4B
$775.4M
Q2 24
$1.4B
$775.6M
Q1 24
$1.5B
$677.1M
Debt / Equity
ABCL
ABCL
CIFR
CIFR
Q4 25
3.37×
Q3 25
1.31×
Q2 25
0.22×
Q1 25
Q4 24
0.00×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ABCL
ABCL
CIFR
CIFR
Operating Cash FlowLast quarter
$-34.7M
$-207.9M
Free Cash FlowOCF − Capex
$-44.6M
$-695.9M
FCF MarginFCF / Revenue
-99.4%
-1165.4%
Capex IntensityCapex / Revenue
21.9%
817.1%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-174.1M
$-1.1B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ABCL
ABCL
CIFR
CIFR
Q4 25
$-34.7M
$-207.9M
Q3 25
$-52.6M
$-50.1M
Q2 25
$-32.4M
$-56.2M
Q1 25
$-11.6M
$-47.2M
Q4 24
$-108.6M
$-87.5M
Q3 24
$-28.9M
$-6.5M
Q2 24
$-30.0M
$-25.4M
Q1 24
$-41.7M
$-26.6M
Free Cash Flow
ABCL
ABCL
CIFR
CIFR
Q4 25
$-44.6M
$-695.9M
Q3 25
$-61.5M
$-256.2M
Q2 25
$-45.8M
$-87.5M
Q1 25
$-22.2M
$-71.8M
Q4 24
$-187.0M
$-227.0M
Q3 24
$-47.4M
$-83.2M
Q2 24
$-50.1M
$-33.2M
Q1 24
$-65.8M
$-34.5M
FCF Margin
ABCL
ABCL
CIFR
CIFR
Q4 25
-99.4%
-1165.4%
Q3 25
-687.0%
-357.3%
Q2 25
-267.9%
-200.9%
Q1 25
-524.0%
-146.7%
Q4 24
-3702.8%
-537.6%
Q3 24
-728.4%
-345.0%
Q2 24
-683.8%
-90.2%
Q1 24
-661.5%
-71.7%
Capex Intensity
ABCL
ABCL
CIFR
CIFR
Q4 25
21.9%
817.1%
Q3 25
99.7%
287.5%
Q2 25
78.2%
71.8%
Q1 25
251.1%
50.2%
Q4 24
1552.7%
330.4%
Q3 24
284.6%
317.8%
Q2 24
274.6%
21.4%
Q1 24
242.5%
16.4%
Cash Conversion
ABCL
ABCL
CIFR
CIFR
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
-5.00×
Q3 24
Q2 24
Q1 24
-0.67×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons